ARTICLE | Clinical News
Vinorelbine emulsion: Completed enrollment in pivotal trial
October 15, 2007 7:00 AM UTC
Adventrx Pharmaceuticals Inc. (ANX), San Diego, Calif. Product: Vinorelbine emulsion ( ANX-530) Business: Cancer Molecular target: NA Description: Emulsion formulation of vinorelbine tartrate Indicati...